Scott Wolchko | President & CEO |
Chris Storgard | CMO |
Dan Shoemaker | CSO |
Nicole Germino | Citigroup |
Ted Tenthoff | Piper Jaffray |
Nick Abbott | Wells Fargo |
Welcome to the Fate Therapeutics Third Quarter 2018 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.